Can Elective Single Embryo Transfer (eSET) with AI Integration Become the Future of IVF?
Journal of IVF-Worldwide · 2025
DOI: 10.46989/001c.130036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of IVF-Worldwide, 2025. Verfasst von Zeev Shoham. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This manuscript examines whether elective single embryo transfer (eSET) should be mandated in all IVF cycles, assessing its clinical benefits, challenges, and global implementation. Evidence shows that eSET significantly reduces multiple pregnancies and associated complications while maintaining cumulative live birth rates. However, ethical, regulatory, and practical considerations complicate universal enforcement. While a standardized eSET policy offers advantages, potential drawbacks include restricted patient autonomy and the need for additional IVF cycles in some instances. To navigate these complexities, the manuscript advocates for a balanced approach: promoting eSET as the preferred standard while allowing individualized decisions based on patient-specific factors. Alternative policy models—such as partial mandates or incentive-based strategies—are explored to enhance outcomes without imposing rigid requirements. This nuanced perspective balances patient safety, treatment efficacy, and shared decision-making in fertility care.
Zitieren
APA
Shoham, Z. (2025). Can Elective Single Embryo Transfer (eSET) with AI Integration Become the Future of IVF?. Journal of IVF-Worldwide. https://doi.org/10.46989/001c.130036
Vancouver
Shoham Z. Can Elective Single Embryo Transfer (eSET) with AI Integration Become the Future of IVF?. Journal of IVF-Worldwide. 2025. doi:10.46989/001c.130036
BibTeX
@article{Shoham2025,
author = {Shoham, Zeev},
title = {Can Elective Single Embryo Transfer (eSET) with AI Integration Become the Future of IVF?},
journal = {Journal of IVF-Worldwide},
year = {2025},
doi = {10.46989/001c.130036}
}
EUVIMED